GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 322 filers reported holding GW PHARMACEUTICALS PLC in Q1 2019. The put-call ratio across all filers is 1.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $14,472,000 | -3.9% | 130,547 | 0.0% | 0.12% | +0.8% |
Q4 2020 | $15,067,000 | +42.7% | 130,547 | +20.4% | 0.12% | +20.2% |
Q3 2020 | $10,555,000 | -28.3% | 108,427 | -9.6% | 0.10% | -36.1% |
Q2 2020 | $14,722,000 | +90.0% | 119,962 | +58.2% | 0.16% | +80.2% |
Q1 2020 | $7,749,000 | -2.2% | 75,811 | 0.0% | 0.09% | +1.2% |
Q4 2019 | $7,927,000 | +34.6% | 75,811 | +48.1% | 0.08% | +9.0% |
Q3 2019 | $5,890,000 | -33.0% | 51,200 | 0.0% | 0.08% | -29.1% |
Q2 2019 | $8,788,000 | +26.5% | 51,200 | +24.3% | 0.11% | +23.6% |
Q1 2019 | $6,945,000 | +73.1% | 41,200 | 0.0% | 0.09% | +43.5% |
Q4 2018 | $4,012,000 | -36.6% | 41,200 | +12.5% | 0.06% | -26.2% |
Q3 2018 | $6,326,000 | +74.9% | 36,620 | +41.3% | 0.08% | +47.4% |
Q2 2018 | $3,617,000 | +37.1% | 25,920 | +10.7% | 0.06% | +26.7% |
Q1 2018 | $2,639,000 | -13.1% | 23,420 | +1.8% | 0.04% | -15.1% |
Q4 2017 | $3,036,000 | +3.2% | 23,000 | -20.7% | 0.05% | +3.9% |
Q3 2017 | $2,943,000 | +22.3% | 29,000 | +20.8% | 0.05% | +13.3% |
Q2 2017 | $2,406,000 | +17.0% | 24,000 | +41.2% | 0.04% | +12.5% |
Q1 2017 | $2,056,000 | +31.5% | 17,000 | +21.4% | 0.04% | +11.1% |
Q4 2016 | $1,564,000 | +7.1% | 14,000 | +27.3% | 0.04% | +2.9% |
Q3 2016 | $1,460,000 | -0.3% | 11,000 | -31.2% | 0.04% | -7.9% |
Q2 2016 | $1,465,000 | – | 16,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|